These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28429248)

  • 1. Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients.
    Faircloth JM; Miner KM; Alsaied T; Nelson N; Ciambarella J; Mizuno T; Palumbo JS; Vinks AA; Veldtman GR
    J Thromb Thrombolysis; 2017 Jul; 44(1):38-47. PubMed ID: 28429248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating time in therapeutic range for hemodialysis patients taking warfarin.
    Quinn LM; Richardson R; Cameron KJ; Battistella M
    Clin Nephrol; 2015 Feb; 83(2):80-5. PubMed ID: 25500296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
    McCrindle BW; Manlhiot C; Cochrane A; Roberts R; Hughes M; Szechtman B; Weintraub R; Andrew M; Monagle P;
    J Am Coll Cardiol; 2013 Jan; 61(3):346-53. PubMed ID: 23246393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting.
    Wittkowsky AK; Nutescu EA; Blackburn J; Mullins J; Hardman J; Mitchell J; Vats V
    Chest; 2006 Nov; 130(5):1385-9. PubMed ID: 17099014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospital.
    Thanimalai S; Shafie AA; Hassali MA; Sinnadurai J
    Int J Clin Pharm; 2013 Oct; 35(5):736-43. PubMed ID: 23715759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics.
    Ohuchi H; Yasuda K; Miyazaki A; Ono S; Hayama Y; Negishi J; Noritake K; Mizuno M; Yamada O
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):511-9. PubMed ID: 24699205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation.
    Egbe AC; Connolly HM; Niaz T; Yogeswaran V; Taggart NW; Qureshi MY; Poterucha JT; Khan AR; Driscoll DJ
    Am Heart J; 2017 Jan; 183():10-17. PubMed ID: 27979032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of warfarin versus aspirin after Fontan surgery.
    Attard C; Monagle PT; d'Udekem Y; Mackay MT; Briody J; Cordina R; Hassan EB; Simm P; Rice K; Ignjatovic V;
    J Thorac Cardiovasc Surg; 2021 Oct; 162(4):1218-1228.e3. PubMed ID: 33563422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
    Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
    J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regional anticoagulation program improves safety and outcomes for both children and adults.
    Rodriguez V; Stanek J; Cua CL; Sankar A; Giver J; Monda K; Canini J; Dunn AL; Kerlin BA
    J Thromb Thrombolysis; 2023 Jul; 56(1):27-36. PubMed ID: 37093351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate term thrombotic risk in contemporary total cavo-pulmonary connection for single ventricle circulations.
    Faircloth JM; Roe O; Alsaied T; Palumbo JS; Vinks A; Veldtman GR
    J Thromb Thrombolysis; 2017 Oct; 44(3):275-280. PubMed ID: 28761995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INR Control of Patients with Mechanical Heart Valve on Long-Term Warfarin Therapy.
    Tan CSY; Fong AYY; Jong YH; Ong TK
    Glob Heart; 2018 Dec; 13(4):241-244. PubMed ID: 30213574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic and Embolic Complications Associated With Atrial Arrhythmia After Fontan Operation: Role of Prophylactic Therapy.
    Egbe AC; Connolly HM; McLeod CJ; Ammash NM; Niaz T; Yogeswaran V; Poterucha JT; Qureshi MY; Driscoll DJ
    J Am Coll Cardiol; 2016 Sep; 68(12):1312-9. PubMed ID: 27634123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation Therapy After the Fontan Procedure.
    Miwa K; Iwai S; Nagashima T
    Pediatr Cardiol; 2022 Aug; 43(6):1271-1276. PubMed ID: 35217887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes.
    Elewa HF; AbdelSamad O; Elmubark AE; Al-Taweel HM; Mohamed A; Kheir N; Mohamed Ibrahim MI; Awaisu A
    J Clin Pharm Ther; 2016 Aug; 41(4):403-8. PubMed ID: 27144477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar.
    Elewa H; Jalali F; Khudair N; Hassaballah N; Abdelsamad O; Mohammed S
    J Eval Clin Pract; 2016 Jun; 22(3):433-8. PubMed ID: 26766552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding and thrombotic risk in pregnant women with Fontan physiology.
    Girnius A; Zentner D; Valente AM; Pieper PG; Economy KE; Ladouceur M; Roos-Hesselink JW; Warshak C; Partington SL; Gao Z; Ollberding N; Faust M; Girnius S; Kaemmerer H; Nagdyman N; Cohen S; Canobbio M; Akagi T; Grewal J; Bradley E; Buber Y; Palumbo J; Walker N; Aboulhosn J; Oechslin E; Baumgartner H; Kurdi W; Book WM; Mulder BJM; Veldtman GR
    Heart; 2021 Sep; 107(17):1390-1397. PubMed ID: 33234672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.
    Monagle P; Cochrane A; Roberts R; Manlhiot C; Weintraub R; Szechtman B; Hughes M; Andrew M; McCrindle BW;
    J Am Coll Cardiol; 2011 Aug; 58(6):645-51. PubMed ID: 21798429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.